[go: up one dir, main page]

CY1108137T1 - Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα - Google Patents

Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα

Info

Publication number
CY1108137T1
CY1108137T1 CY20081100626T CY081100626T CY1108137T1 CY 1108137 T1 CY1108137 T1 CY 1108137T1 CY 20081100626 T CY20081100626 T CY 20081100626T CY 081100626 T CY081100626 T CY 081100626T CY 1108137 T1 CY1108137 T1 CY 1108137T1
Authority
CY
Cyprus
Prior art keywords
hydro
alkania
fluor
promotional
inhibitor
Prior art date
Application number
CY20081100626T
Other languages
English (en)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc. filed Critical Boehringer Ingelheim Pharmaceuticals Inc.
Publication of CY1108137T1 publication Critical patent/CY1108137T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Μια βελτιωμένη σύνθεση εναιωρήματος περιγράφεται για χρήση σε ένα εισπνευστήρα δοσομετρημένης δόσης που έχει υδρο-φθορο-αλκανίου, με τη βελτίωση να είναι η ελεγχόμενη προσθήκη μιας μικρής ποσότητας νερού.
CY20081100626T 2003-03-20 2008-06-11 Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα CY1108137T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
EP04757846A EP1608336B1 (en) 2003-03-20 2004-03-19 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants

Publications (1)

Publication Number Publication Date
CY1108137T1 true CY1108137T1 (el) 2014-02-12

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100626T CY1108137T1 (el) 2003-03-20 2008-06-11 Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα

Country Status (28)

Country Link
US (1) US7914770B2 (el)
EP (1) EP1608336B1 (el)
JP (1) JP4708332B2 (el)
KR (1) KR101113003B1 (el)
CN (1) CN1761455A (el)
AT (1) ATE390125T1 (el)
AU (1) AU2004224367B2 (el)
BR (1) BRPI0408547A (el)
CA (1) CA2519523C (el)
CO (1) CO5640070A2 (el)
CY (1) CY1108137T1 (el)
DE (1) DE602004012718T2 (el)
DK (1) DK1608336T3 (el)
EA (1) EA009087B1 (el)
EC (1) ECSP056029A (el)
ES (1) ES2304616T3 (el)
HR (1) HRP20050822B1 (el)
ME (1) ME00420B (el)
MX (1) MXPA05009920A (el)
NO (1) NO336457B1 (el)
NZ (1) NZ542957A (el)
PL (1) PL1608336T3 (el)
PT (1) PT1608336E (el)
RS (1) RS51663B (el)
SI (1) SI1608336T1 (el)
UA (1) UA89751C2 (el)
WO (1) WO2004084858A2 (el)
ZA (1) ZA200506463B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
EP1809243B2 (de) * 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2187969A2 (en) * 2007-08-17 2010-05-26 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
CN106456913B (zh) 2014-05-07 2019-08-30 勃林格殷格翰国际有限公司 喷雾器和容器
WO2016164508A1 (en) * 2015-04-10 2016-10-13 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2021216779A1 (en) * 2020-04-21 2021-10-28 Amphastar Pharmaceuticals, Inc. Anti-viral pharmaceutical formulations administered via devices for lung targeted delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
EP0960830A1 (en) * 1993-04-30 1999-12-01 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
CA2166970C (en) 1993-07-15 2000-12-19 Oh-Seung Kwon Seals for use in an aerosol delivery device
DE69631476T2 (de) * 1995-04-14 2005-01-13 Smithkline Beecham Corp. Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
EP1414508B1 (en) 2001-06-26 2011-04-20 Norton Healthcare Limited An improved aerosol actuator

Also Published As

Publication number Publication date
CO5640070A2 (es) 2006-05-31
KR20050111382A (ko) 2005-11-24
US7914770B2 (en) 2011-03-29
ES2304616T3 (es) 2008-10-16
BRPI0408547A (pt) 2006-03-07
JP2006520797A (ja) 2006-09-14
CA2519523C (en) 2012-03-13
RS51663B (sr) 2011-10-31
CA2519523A1 (en) 2004-10-07
MXPA05009920A (es) 2005-11-04
US20040184994A1 (en) 2004-09-23
ECSP056029A (es) 2006-01-27
ZA200506463B (en) 2006-04-26
AU2004224367B2 (en) 2009-10-08
EA200501363A1 (ru) 2006-04-28
ME00420B (me) 2011-12-20
JP4708332B2 (ja) 2011-06-22
NO20054839L (no) 2005-10-19
RS20050705A (sr) 2008-04-04
CN1761455A (zh) 2006-04-19
KR101113003B1 (ko) 2012-02-24
EP1608336A2 (en) 2005-12-28
HRP20050822B1 (hr) 2013-09-30
WO2004084858A2 (en) 2004-10-07
WO2004084858A3 (en) 2004-11-04
AU2004224367A1 (en) 2004-10-07
NZ542957A (en) 2008-09-26
EP1608336B1 (en) 2008-03-26
PL1608336T3 (pl) 2008-09-30
DK1608336T3 (da) 2008-06-02
HRP20050822A2 (en) 2006-10-31
ATE390125T1 (de) 2008-04-15
EA009087B1 (ru) 2007-10-26
SI1608336T1 (sl) 2008-08-31
PT1608336E (pt) 2008-04-21
DE602004012718T2 (de) 2009-05-07
UA89751C2 (ru) 2010-03-10
NO336457B1 (no) 2015-08-31
DE602004012718D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
CY1108137T1 (el) Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα
TNSN07020A1 (en) Her2 antibody composition
TW200510375A (en) New compounds
SE0301700D0 (sv) Novel compounds
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AR034298A1 (es) Una valvula dosificadora para un inhalador de dosis dosificada que mejora el flujo de la formulacion a la camara dosificadora
ECSP10010265A (es) Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8 dihidro-9h-purin-9-il)propil](3-morfolin-4 ilpropil)amino]metil}fenil)
SE0301653D0 (sv) Novel compounds
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
SE0403171D0 (sv) New compounds
GB0323684D0 (en) Improvements in or relating to organic compounds
TW200745122A (en) New compounds I
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
TW200736227A (en) New compounds III
SE0402284D0 (sv) New heterocyclic amides
ATE396177T1 (de) Neue kristalline formen eines faktor xa inhibitors
SE0403118D0 (sv) New compounds 2
TW200745133A (en) New compounds II
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
TW200720262A (en) Novel compounds ii
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
MX2008007195A (es) Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.
SE0403117D0 (sv) New compounds 1
PA8593701A1 (es) [4-(3-aminometilfenil)piperidin-1-il]-[5-(2-fluorofenil-etinil)furan-2-il]-metanoma como inhibidor de triptasa de mastocitos